Papers: 10.1038/s41389-018-0093-z

https://doi.org/10.1038/s41389-018-0093-z

Development and evaluation of a novel series of Nitroxoline-derived BET inhibitors with antitumor activity in renal cell carcinoma

Cited by: 8
Author(s): Wei Chen, Hao Zhang, Zhifeng Chen, Hao Jiang, Liping Liao, Shijie Fan, Jing Xing, Yiqian Xie, Shijie Chen, Hong Ding, Kaixian Chen, Hualiang Jiang, Cheng Luo, Mingyue Zheng, Zhiyi Yao, Yiran Huang, Yuanyuan Zhang
Published: over 6 years ago

Software Mentions 2